Clinical trial
Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic…
NCT00078533 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00078533 |
|---|---|
| Title | Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant |
| Official title | Virus Specific Cytotoxic T-Lymphocytes for the Treatment of CMV After Allogeneic Stem Cell Transplant: A Dose-Finding Trial |
| Acronym | VICTA |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | Center for Cell and Gene Therapy, Baylor College of Medicine The Methodist Hospital Research Institute National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cytomegalovirus Infections |
| Intervention type | Biological |
| Interventions | CMV CTL infusion |
| Enrollment | 26 |
| Start date | Apr 1, 2004 |
| Primary completion | Jul 1, 2010 |
| Completion | Jun 1, 2011 |
| First posted | Mar 2, 2004 |
| Last update posted | Oct 8, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: